Software - ANVISA Registration 81464750147
Access comprehensive regulatory information for Software in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81464750147 and manufactured by NEUROGRAM INC.. The registration is held by Domo Salute Consultoria Regulatória Ltda with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
81464750147
25351156214202466
26263959000103
Company Information
Dates and Status
May 13, 2024
VIGENTE
09/18/2025 19:00:01
Software
myNight
RESMED CORP.
82507520002
Feb 27, 2023
Software
CALLISTO EYE
CARL ZEISS MEDITEC AG.
10332039079
Mar 12, 2012
Software
AOS ANTERIOR
ADVANCED OPHTHALMIC SYSTEMS LTD (AOS)
80891629004
Apr 09, 2018
Software
HYBRISOFT HSHS
VITRO, S.A
80502079001
Apr 10, 2017
SOFTWARE FOR MEDICAL IMAGE PROCESSING
APNEIA
CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA
10361059008
Dec 18, 2017
Software
Calculadora VDZ-CDST
TAKEDA PHARMACEUTICALS U.S.A., INC.
80147410026
Sep 15, 2025
Software
P4C
DEDALUS ITALIA SPA
81806320006
Sep 15, 2025
Software
AFOOT AI
LOOKINSIDE SERVICOS E TECNOLOGIAS LTDA
83126510001
Sep 08, 2025
Software
MV PEP
MV SISTEMAS DE MEDICINA DIAGNOSTICA LTDA
80436840006
Sep 08, 2025
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
83084440002
Aug 18, 2025